Chair in Emerging Technologies 2018
Professor Denison is working to improve treatments for diseases of the nervous system. For invasive devices that are implanted in the body, Professor Denison’s team has collaborated with UK-based Bioinduction Ltd (Bristol) to create the “Picostim DyNeuMo” research platform based on their Picostim neurostimulator. The Picostim DyNeuMo research platform is exploring advanced therapy concepts to the research clinic; the first motion-adaptive system, which works like a programmable bioengineered reflex, was implanted in early 2022 as part of a research protocol developing treatments for autonomic disorders. For minimally invasive systems, Professor Denison is working to advance transcranial magnetic stimulation for brain disorders such as anxiety in collaboration with UK-based Magstim Ltd (Whitland, Wales). Professor Denison hopes to bring new solutions for the treatment of mental health disorders through advanced power electronics, machine learning, and feedback control. These technologies should provide a more patient-specific therapy for diseases poorly served with existing treatments.
Personal website: https://eng.ox.ac.uk/people/tim-denison/